title: Medication highlights: new recommendations for palivizumab (Synagis).
authors.forename: Jody
authors.initials: J
authors.lastname: Ridky
mesh_terms: D003131:Combined Modality Therapy / Q000451:nursing; D004334:Drug Administration Schedule; D015199:Extracorporeal Membrane Oxygenation / Q000451:nursing; D019983:Guideline Adherence; D006760:Hospitalization; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000451:nursing* / Q000517:prevention & control*; D000069455:Palivizumab / Q000627:therapeutic use*; D018357:Respiratory Syncytial Virus Infections / Q000451:nursing* / Q000517:prevention & control*; D012307:Risk Factors
chemical_list: D000069455:Palivizumab